rxstat › Shortages › Sitagliptin

Sitagliptin (Januvia) shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Oct 12, 2026

Some Sitagliptin products are in shortage in Canada (10 of 24 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.

A diabetes medication used to help control blood sugar in type 2 diabetes.

Products affected
10 / 24
In shortage since
Mar 20, 2024
Reports on file
49
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Book a pharmacist appointment
Need your prescription switched?
If your product stays unavailable, an online doctor can assess your situation and prescribe an alternative.
See a doctor online

Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.

Shortage history

2023 2024 2025 2026

Shortage history (red bands = periods in shortage).

Reports by product

The DIN is printed on your prescription label.

Active shortage
TARO-SITAGLIPTIN FUMARATE
25MG · TABLET · TARO PHARMACEUTICALS INC
DIN 02531631 · since Jun 1, 2026, est. end Oct 16, 2026 · Disruption of the manufacture of the drug.
Active shortage
APO-SITAGLIPTIN MALATE
100MG · TABLET · APOTEX INC
DIN 02508672 · since Aug 12, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-SITAGLIPTIN MALATE
100MG · TABLET · APOTEX INC
DIN 02508672 · since Oct 14, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-SITAGLIPTIN MALATE
50MG · TABLET · APOTEX INC
DIN 02508664 · since Nov 4, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-SITAGLIPTIN MALATE
50MG · TABLET · APOTEX INC
DIN 02508664 · since Nov 18, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-SITAGLIPTIN MALATE
25MG · TABLET · APOTEX INC
DIN 02508656 · since Oct 14, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-SITAGLIPTIN MALATE
25MG · TABLET · APOTEX INC
DIN 02508656 · since Oct 14, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-SITAGLIPTIN MALATE
100MG · TABLET · APOTEX INC
DIN 02508672 · since Oct 14, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
TEVA-SITAGLIPTIN MALATE
50MG · TABLET · TEVA CANADA LIMITED
DIN 02522713 · since Mar 5, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
TEVA-SITAGLIPTIN MALATE
25MG · TABLET · TEVA CANADA LIMITED
DIN 02522705 · since Mar 5, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
TEVA-SITAGLIPTIN MALATE
100MG · TABLET · TEVA CANADA LIMITED
DIN 02522721 · since Mar 5, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
ACH-SITAGLIPTIN
100MG · TABLET · ACCORD HEALTHCARE INC
DIN 02512491 · since Mar 20, 2024, no end estimate · Requirements related to complying with good manufacturing practices.

Showing 12 of 49 reports. All reports are on file with Health Canada.

What's happening

Sitagliptin is currently affected by 10 active shortage reports filed with Health Canada by TARO PHARMACEUTICALS INC, APOTEX INC, TEVA CANADA LIMITED, ACCORD HEALTHCARE INC.

The reported causes are: disruption of the manufacture of the drug; requirements related to complying with good manufacturing practices. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Sitagliptin is classified under “BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS” (ATC A10BH).

Recent changes

Common questions

What is Sitagliptin used for?

A diabetes medication used to help control blood sugar in type 2 diabetes.

When will Sitagliptin be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Sitagliptin in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Possible alternatives in the same class (blood glucose lowering drugs, excl. insulins)

Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.

Dulaglutide (Trulicity) No current shortage Liraglutide (Victoza) No current shortage Dapagliflozin Partial shortage 4 of 11 reported products affected Dapagliflozin Metformin (Xigduo) Partial shortage 2 of 6 reported products affected · est. return Dec 18, 2026 Gliclazide (Diamicron Mr) Partial shortage 2 of 20 reported products affected Metformin (Glucophage) Partial shortage 3 of 33 reported products affected

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.